Renephra
Manchester, Manchester, United Kingdom
About Renephra
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $596.3K
- Last round: Series Unknown (Dec 2018)
- Website: renephra.com
- Phone: +44 161 667 1089
Industries & Categories
Health Care, Health Diagnostics, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/renephra-2253059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.